AEPCX
Price
$62.88
Change
+$0.19 (+0.30%)
Updated
Oct 24 closing price
Net Assets
138.04B
FNGZX
Price
$18.69
Change
+$0.09 (+0.48%)
Updated
Oct 24 closing price
Net Assets
821.42M
Interact to see
Advertisement

AEPCX vs FNGZX

Header iconAEPCX vs FNGZX Comparison
Open Charts AEPCX vs FNGZXBanner chart's image
American Funds EUPAC C
Price$62.88
Change+$0.19 (+0.30%)
VolumeN/A
Net Assets138.04B
Franklin Intl Growth Adv
Price$18.69
Change+$0.09 (+0.48%)
VolumeN/A
Net Assets821.42M
AEPCX vs FNGZX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. FNGZX commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and FNGZX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 138B vs. FNGZX (821M). FNGZX pays higher dividends than AEPCX: FNGZX (1.84) vs AEPCX (0.16). AEPCX was incepted earlier than FNGZX: AEPCX (25 years) vs FNGZX (17 years). AEPCX (1.57) is less costly to investors than FNGZX (0.95). AEPCX is a more actively managed with annual turnover of: 35.00 vs. FNGZX (17.56). AEPCX has a lower initial minimum investment than FNGZX: AEPCX (250) vs FNGZX (100000). AEPCX annual gain was more profitable for investors over the last year : 12.10 vs. FNGZX (9.02). AEPCX return over 5 years is better than : 10.66 vs. FNGZX (-2.16).
AEPCXFNGZXAEPCX / FNGZX
Total Expense Ratio1.570.87180%
Annual Report Gross Expense Ratio1.570.95165%
Fund Existence25 years17 years-
Gain YTD21.69514.452150%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets138B821M16,809%
Annual Yield % from dividends0.161.849%
Returns for 1 year12.109.02134%
Returns for 3 years45.1340.39112%
Returns for 5 years10.66-2.16-494%
Returns for 10 years36.6582.0745%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIVS2.330.13
+5.91%
VivoSim Lab Inc
XYF12.880.21
+1.66%
X Financial
ORMP2.390.02
+0.84%
Oramed Pharmaceuticals
H148.870.56
+0.38%
Hyatt Hotels Corp
PRDO36.880.05
+0.14%
Perdoceo Education Corp